Journals / Solunum / 2009 / Cilt: 11 - Sayı: 1

Assessment of the relationship between pulmonary functions, duration and severity of disease with walking and BODE index in COPD

KOAH'lı hastalarda hastalık süresi ve şiddeti ile solunum fonksiyon testleri, yürüme ve bode indeksi arasındaki ilişkinin değerlendirilmesi

Journal
Solunum
Pages
22–25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Both severity and duration of diseases have been found to be related with dyspnea and BODE index and this reveals that physiological measurement as well as symptoms quantified assessment are necessary to take part in the following of patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of our study was assessment of pulmonary functions, walking and BODE index and evaluation of relationship with duration and severity of disease in COPD.
📊
Key Findings & Data:Patients performed pulmonary function tests (PFT) and six minute walking test (6 MWT).
💡
Conclusion & Impact:Conclusion: Both severity and duration of diseases have been found to be related with dyspnea and BODE index and this reveals that physiological measurement as well as symptoms quantified assessment are necessary to take part in the following of patients.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Oksijen tüketimi · Solunum fonksiyon testleri · Yürüme

Abstract

Aim: The aim of our study was assessment of pulmonary functions, walking and BODE index and evaluation of relationship with duration and severity of disease in COPD. Material and method: Twenty-five male patients with stable COPD participated in the study. Patients performed pulmonary function tests (PFT) and six minute walking test (6 MWT). Dyspnea of patients was estimated by ?Modified Medical Research Dyspnea Scale?, visual analog dyspnea scale (VAS) and Borg scale. BODE index, myocardial oxygen consumption (MVO2) and six minute walking work were calculated. Results: Body mass index (BMI) were 28.2±2.7 kg/m2, predicted forced expiratory volume in first second (FEV1) were %56.8±22.7 (1.45±0.55 lt), maximal inspiratory pressures (PImax) were 71.7±26.6 cm H2O, maximal expiratory pressures were 74.7±40.5 cm H2O in PFT. Six minute walking distance was 366±65 m. MVO2, dyspnea (VAS and Borg) and oxygen saturation were significantly changed after the 6 MWT (p< 0.001). Severity of disease has shown significantly relationship with %FEV1, %FVC, FEV2/FVC, dyspnea (MMRC), BODE index (rs=-0.955, p<0.001; rs=0.793, p<0.001; rs=-0.556, p=0.04; rs=0.527, p=0.007; rs=0.775, respectively; p<0.001 for all ), dyspnea (VAS) and MVO2 in 6 MWT (rs=0.609, p=0.001; rs=0.453 respectively; p=0.02 for all). Multiple lineer regression model was developed for this relationship. y=-0.03 FEV1 (%)+0.15 dyspnea (VAS)+0.08 BODE (F=93.38, p<0.001; R=0.96, R2=0.93) was found. Duration of disease was significantly related with BODE index (rs=0.525, p=0.007), dyspnea (MMRC) (rs=0.571, p=0.003), 6 MWD (rs=- 0.635, p= 0.001), and dyspnea change (VAS) in 6 MWT (rs=0.533, p= 0.006). Duration of disease=0.38 dyspnea (MMRC) -0.30 (F=7.78, p=0.01, R=0.50, R2=0.25) was found in multiple lineer regression analyses. Conclusion: Both severity and duration of diseases have been found to be related with dyspnea and BODE index and this reveals that physiological measurement as well as symptoms quantified assessment are necessary to take part in the following of patients.

Özet

Amaç: Çalışmamızın amacı KOAH?lı hastalarda solunum fonksiyonları, yürüme ve BODE indeksini değerlendirerek bu verilerin hastalık süresi ve şiddeti ile aralarındaki ilişkiyi araştırmaktı. Gereç ve yöntem: Çalışmaya gönüllü, 25 stabil KOAH?lı erkek hasta alındı. Hastalara solunum fonksiyon testi (SFT), 6 dakika yürüme testi (6DYT) yapıldı. Hastaları n dispneleri ?Modifiye Medical Research Council? (MMRC), vizüel analog skala (VAS) ve Borg skalası ile belirlendi. BODE indeksi, miyokardial oksijen tüketimi (MVO2) ve 6 dakika yürüme işi (6DYİ) hesaplandı. Bulgular: Hastaların yaş ortalaması 66.8±9.2 yıldı. Beden kitle indeksleri (BKİ) 28.2±2.7 kg/m2, SFT?nde FEV1 ortalaması %56.8±22.7 (1.45±0.55 L), maksimal inspiratuar basınç (PImaks) ortalama 71.7±26.6 cm H2O, maksimal ekspiratuar basınç (PEmaks) ortalama 74.7±40,5 cm H2O idi. Altı dakika yürüme mesafesi (6DYM) ortalama 366±65 m idi. Altı DYT sonunda MVO2, dispne (VAS ve Borg) ve oksijen satürasyonu (SaO2) anlamlı derecede değişti (p<0.001). Hastalık şiddeti; %FEV1, %FVC, FEV1/FVC, dispne (MMRC), BODE indeksi ile (sırasıyla; rs=-0.955, p<0.001; rs=0.793, p<0.001; rs=-0.556, p=0.04; rs=0.527, p=0.007; rs=0.775, p<0.001) ve 6DYT sırasındaki dispne (VAS) ve MVO2 değişimleriyle (sırasıyla; rs=0.609, p=0.001; rs=0.453, p=0.02) anlamlı ilişki göstermekteydi. Bu ilişkilere yönelik çoklu lineer regresyon modeli oluşturuldu: y=-0.03 FEV1 (%)+0.15 dispne (VAS)+0.08 BODE (F=93.38, p<0.001; R=0.96, R2=0.93) olarak bulundu. Hastalık süresi; BODE indeksi (rs=0.525, p=0.007), dispne (MMRC) (rs=0.571, p=0.003), 6DYM (rs=-0.635, p= 0.001), 6DYT sırasındaki dispne değişimi (VAS) (rs=0.533, p=0.006) ile anlamlı olarak ilişkiliydi. Bu ilişkilere yönelik çoklu regresyon modeli oluşturuldu. Hastalık süresi= 0.38 dispne (MMRC) -0.30 (F=7.78, p=0.01, R=0.50, R2=0.25) olarak bulundu. Sonuç: Hem hastalık şiddeti hem de hastalık süresinin dispne (MMRC ve VAS) ve BODE indeksi ile ilişkili bulunması, fizyolojik ölçümlerin yanı sıra semptomların da nicel olarak değerlendirilmesinin takipte yer alması gerektiğini ortaya koymaktadır.

🔖

Cite This Article

KURAN, G., YELDAN, İ., İŞSEVER, H., ERKAN, F., GÜRSES, H. N. (2009). Assessment of the relationship between pulmonary functions, duration and severity of disease with walking and BODE index in COPD. Solunum, Cilt: 11 - Sayı: 1, 22–25. https://ajindex.com/articles/316258

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Ulusal Hastalık Yükü ve Maliyet Etkililik Projesi (Sağlık Bakanlığı, 2000
  2. Cote CG, Celi BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005;26:630-636
  3. Hajiro T, Nishimura K, Tsukino M, et al. A comparison of the level of dyspnea vs disease severity in indicating the health related quality of life of patients with COPD. Chest 1999; 116:1632-1637
  4. Mahler DA, Criner GJ. Assessment tools for chronic obstructive pulmonary disease: Do newer metrics allow for disease modification? Proc Am Thorac Soc 2007;4:507-511
  5. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD. Date last accessed: July 13 2006. Date last updated: 2005
  6. Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS Task Force: Standardisation of lung function testing. Eur Respir J 2005;26:319-338
  7. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117
  8. Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14: 377-381
  9. Mador MJ, Kufel TJ. Reproducibility of visual analog scale measurements of dyspnea in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146:82-87
  10. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-586
  11. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350;1005-1012
  12. Carter R, Holiday DB, Nwasuruba C, et al. 6-minute walk work for assessment of functional capacity in patients with COPD. Chest 2003;123:1408-1415
  13. Gürses HN. KOAH’ta rehabilitasyon. In: Umut S, Yıldırım N, eds. Kronik obstrüktif akciğer hastalıkları. ‹stanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Göğüs Hastalıkları Anabilim Dalı Kitap Dizisi- 4. İstanbul, 2005
  14. Ruiz de Oña Lacasta JM, García de Pedro J, Puente Maestu L, et al. Effects of muscle training on breathing pattern in patients with severe chronic obstructive pulmonary disease. Arch Bronconeumol 2004;40:20-23
  15. Schlecht NF, Schwartzman K, Bourbeau J. Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease. Chron Respir Dis 2005;2:183-191
  16. Celi BR, Calverley PMA, Rennardc SI, et al. Proposal for a multidimensional staging s